NIAGEN BIOSCIENCE, INC. Income (Loss) from Continuing Operations, Per Diluted Share
NIAGEN BIOSCIENCE, INC. (NAGE) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.16 per share for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2018-11-07
- NIAGEN BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2018-09-30 was -$0.16.
- NIAGEN BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2017-09-30 was -$0.07.
- NIAGEN BIOSCIENCE, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-10-01 was -$0.02.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month |
|---|---|---|
| 2018-09-30 | -$0.16 10-Q · filed 2018-11-07 | |
| 2017-09-30 | -$0.07 10-Q · filed 2018-11-07 | -$0.18 10-Q · filed 2017-11-09 |
| 2016-10-01 | -$0.02 10-Q · filed 2017-11-09 | -$0.04 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |